Your browser doesn't support javascript.
loading
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.
Dufies, Maeva; Nollet, Marie; Ambrosetti, Damien; Traboulsi, Wael; Viotti, Julien; Borchiellini, Delphine; Grépin, Renaud; Parola, Julien; Giuliano, Sandy; Helley-Russick, Dominique; Bensalah, Karim; Ravaud, Alain; Bernhard, Jean-Christophe; Schiappa, Renaud; Bardin, Nathalie; Dignat-George, Françoise; Rioux-Leclercq, Nathalie; Oudard, Stephane; Négrier, Sylvie; Ferrero, Jean-Marc; Chamorey, Emmanuel; Blot-Chabaud, Marcel; Pagès, Gilles.
Afiliação
  • Dufies M; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco.
  • Nollet M; Aix Marseille Univ, INSERM 1263, INRA 1260, C2VN, Marseille, France.
  • Ambrosetti D; University Cote d'Azur, Nice University Hospital, Department of Pathology.
  • Traboulsi W; Aix Marseille Univ, INSERM 1263, INRA 1260, C2VN, Marseille, France.
  • Viotti J; Centre Antoine Lacassagne, Statistic department, Nice, France.
  • Borchiellini D; Centre Antoine Lacassagne, Clinical research department Nice, France.
  • Grépin R; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco.
  • Parola J; University Cote d'Azur, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France.
  • Giuliano S; Centre Scientifique de Monaco, Biomedical Department, 8 Quai Antoine Ier, MC-98000 Monaco, Principality of Monaco.
  • Helley-Russick D; European Hospital Georges Pompidou, Paris, France.
  • Bensalah K; Centre Hospitalier Universitaire (CHU) de Pontchaillou Rennes, service d'urologie.
  • Ravaud A; Bordeaux University, Bordeaux University Hospital (CHU), Medical Oncology department, Bordeaux, France.
  • Bernhard JC; Bordeaux University, Bordeaux University Hospital (CHU), Urology department, Bordeaux, France.
  • Schiappa R; Centre Antoine Lacassagne, Statistic department, Nice, France.
  • Bardin N; Aix Marseille Univ, INSERM 1263, INRA 1260, C2VN, Marseille, France.
  • Dignat-George F; Aix Marseille Univ, INSERM 1263, INRA 1260, C2VN, Marseille, France.
  • Rioux-Leclercq N; Rennes University, Rennes University Hospital, Department of Pathology, Rennes, France.
  • Oudard S; European Hospital Georges Pompidou, Paris, France.
  • Négrier S; Centre Léon Bérard, Lyon, France.
  • Ferrero JM; Centre Antoine Lacassagne, Clinical research department Nice, France.
  • Chamorey E; Centre Antoine Lacassagne, Statistic department, Nice, France.
  • Blot-Chabaud M; Aix Marseille Univ, INSERM 1263, INRA 1260, C2VN, Marseille, France.
  • Pagès G; University Cote d'Azur, Institute for research on cancer and aging of Nice, CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, France.
Theranostics ; 8(9): 2447-2458, 2018.
Article em En | MEDLINE | ID: mdl-29721091
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Sunitinibe / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Sunitinibe / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article